SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-22-035391
Filing Date
2022-06-28
Accepted
2022-06-28 08:00:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea161466-424b3_actinium.htm 424B3 41799
2 GRAPHIC image_001.jpg GRAPHIC 6717
  Complete submission text file 0001213900-22-035391.txt   52255
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-242322 | Film No.: 221046514
SIC: 2834 Pharmaceutical Preparations